Onureg

DRUG2 trials

Sponsors

Bristol-Myers Squibb, Hikma Pharmaceuticals LLC

Conditions

Acute Myeloid LeukaemiaHepatic InsufficiencyNeoplasms

Phase 1

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

TerminatedNCT05209295

Bristol-Myers SquibbHepatic Insufficiency, Neoplasms

Start: 2024-07-12End: 2025-04-20Updated: 2026-01-12

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

CompletedNCT06326697

Hikma Pharmaceuticals LLCAcute Myeloid Leukaemia

Start: 2024-05-02End: 2025-08-28Updated: 2025-09-26